NCT00000374 - Treatment for First-Episode Schizophrenia | Biotech Hunter

Enrollment

125

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Schizophrenia

Interventions

DRUG

Olanzapine

The dosage for Olanzapine will be 2.5 mg to 20mg per day. The dose of the Olanzapine will be based on the participant's clinical improvement and side effects.

DRUG

Risperidone

The dosage for Risperidone will be 1 mg to 6mg per day. The dose of the Risperidone will be based on the participant's clinical improvement and side effects.

Trial Locations (2)

10456

Bronx-Lebanon Hospital Center, The Bronx

11004

Hillside Hospital, Glen Oaks